Dindin, Cerilo C.
HRN: 25-63-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/12/2026
01/18/2026
Q48
750
Q48
HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes